Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artificial Liushen Pill (人工六神丸) is a traditional Chinese medicine (TCM) developed and manufactured by Changshu Leiyunshang Pharmaceutical. It is a modern variation of the classic Liushen Pill formulation, substituting rare and regulated natural musk with artificial musk, while retaining other traditional active ingredients such as realgar and toad venom. The formulation is widely used in China for its heat-clearing, detoxicating, anti-inflammatory, and analgesic properties. It is primarily indicated for the treatment of acute tonsillitis, pharyngitis, sore throat, and various inflammatory skin conditions such as boils and carbuncles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on artificial liushen pill.